New Jersey · 19082

Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth in New Jersey

New Jersey Medicare Avg
$173.27
20% above national avg
National Medicare Avg
$144.96
All states combined
Billed Charge (NJ)
$1,323.09
What providers submit
Est. Commercial (NJ)
$555.53
National avg: $407.70
Est. Cash / Self-Pay (NJ)
$527.24
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

176
Services in NJ
79
Providers
N/A
Min Payment
N/A
Max Payment

New Jersey Pricing in Context

In New Jersey, CPT code 19082 (Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth) carries an average Medicare payment of $173.27 — 20% above the national benchmark of $144.96. 79 providers across the state submitted claims for this procedure in 2023, performing 176 total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Jersey is $1,323.09, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in New Jersey lands near $555.53, with self-pay cash prices typically around $527.24. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth cost in New Jersey?

The average Medicare payment for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth in New Jersey is $173.27, which is 20% above the national average of $144.96. Providers in NJ typically bill $1,323.09 for this procedure.

What does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth cost with insurance in New Jersey?

With commercial insurance in New Jersey, Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth costs an estimated $555.53. Without insurance, the estimated cash price is $527.24. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth in New Jersey?

79 providers in New Jersey billed Medicare for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth in 2023, performing 176 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth cheaper in New Jersey than the national average?

No — Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, Each Additional Growth costs 20% above the national average in New Jersey. The state average Medicare payment is $173.27 compared to $144.96 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial